Spread of epidemic clostridium difficile NAP1/027 in Latin America: Case reports in panama

Journal of Medical Microbiology

Volumn 63, Issue PART 2, 2014, Pages 322-324

  Lopez Urena, Diana ^a   Quesada Gomez, Carlos ^a   Miranda, Erick ^b   Fonseca, Mercedes ^c   Rodríguez Cavallini, Evelyn ^a  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^b Caja Seguro Social ^*  (Panama)

^c Departamento de Medicina Interna   (Panama)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; LEVOFLOXACIN; METRONIDAZOLE; MOXIFLOXACIN; QUINOLONE DERIVATIVE; RIFAMPICIN; VANCOMYCIN;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CDTB GENE; CLOSTRIDIUM DIFFICILE INFECTION; DIABETES MELLITUS; EPIDEMIC; EPSILOMETER TEST; GENE DELETION; HUMAN; KIDNEY DISEASE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; PANAMA; PRIORITY JOURNAL; RECURRENT INFECTION; TCDA GENE; TCDB GENE; TCDC GENE; URINARY DYSFUNCTION;

AGED; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; EPIDEMICS; GENOTYPE; HUMANS; PANAMA;

EID: 84893005751     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.066399-0     Document Type: Article

References (16)

1. Denève, C., Janoir, C., Poilane, I., Fantinato, C. & Collignon, A. (2009). New trends in Clostridium difficile virulence and pathogenesis. Int J Antimicrob Agents 33 (Suppl 1), S24-S28.
2. Dubberke, E. R., Reske, K. A., Yan, Y., Olsen, M. A., McDonald, L. C. & Fraser, V. J. (2007). Clostridium difficile - associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 45, 1543-1549.
3. Freeman, J., Bauer, M. P., Baines, S. D., Corver, J., Fawley, W. N., Goorhuis, B., Kuijper, E. J. & Wilcox, M. H. (2010). The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 23, 529-549.
4. Hecht, D., Citron, D. M., Cox, M., Jacobus, N., Jenkins, S. G., Onderdonk, A., Roe-Carpenter, D., Rosenblatt, J. E. & Wexler, H. M. (2007). Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard, 7th edn, Clinical and Laboratory Standards Institute document M11-A7 27, 1-47. Wayne, PA: Clinical and Laboratory Standards Institute.
5. Hernández-Rocha, C., Barra-Carrasco, J., Pizarro-Guajardo, M., Ibáñez, P., Bueno, S. M., Sarker, M. R., Guzmán, A. M., Alvarez-Lobos, M. & Paredes-Sabja, D. (2012). Epidemic Clostridium difficile ribotype 027 in Chile. Emerg Infect Dis 18, 1370-1372.
6. Labbé, A.-C., Poirier, L., MacCannell, D., Louie, T., Savoie, M., Béliveau, C., Laverdière, M. & Pépin, J. (2008). Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. Antimicrob Agents Chemother 52, 3180-3187.
7. Limbago, B. M., Long, C. M., Thompson, A. D., Killgore, G. E., Hannett, G. E., Havill, N. L., Mickelson, S., Lathrop, S., Jones, T. F. & other authors (2009). Clostridium difficile strains from community-associated infections. J Clin Microbiol 47, 3004-3007.
8. Loo, V. G., Poirier, L., Miller, M. A., Oughton, M., Libman, M. D., Michaud, S., Bourgault, A. M., Nguyen, T., Frenette, C. & other authors (2005). A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353, 2442-2449.
9. McDonald, L. C., Killgore, G. E., Thompson, A., Owens, R. C., Jr, Kazakova, S. V., Sambol, S. P., Johnson, S. & Gerding, D. N. (2005). An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353, 2433-2441.
10. Miller, M., Gravel, D., Mulvey, M., Taylor, G., Boyd, D., Simor, A., Gardam, M., McGeer, A., Hutchinson, J. & other authors (2010). Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis 50, 194-201.
11. Morgan, O. W., Rodrigues, B., Elston, T., Verlander, N. Q., Brown, D. F. J., Brazier, J. & Reacher, M. (2008). Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study. PLoS ONE 3, e1812.
12. O'Connor, J. R., Johnson, S. & Gerding, D. N. (2009). Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 136, 1913-1924.
13. Pépin, J., Valiquette, L., Alary, M. E., Villemure, P., Pelletier, A., Forget, K., Pépin, K. & Chouinard, D. (2004). Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 171, 466-472.
14. Quesada-Gómez, C., Rodríguez, C., Gamboa-Coronado, M. M., Rodríguez-Cavallini, E., Du, T., Mulvey, M. R., Villalobos-Zúñiga, M. & Boza-Cordero, R. (2010). Emergence of Clostridium difficile NAP1 in Latin America. J Clin Microbiol 48, 669-670.
15. Razavi, B., Apisarnthanarak, A. & Mundy, L. M. (2007). Clostridium difficile: emergence of hypervirulence and fluoroquinolone resistance. Infection 35, 300-307.
16. Spigaglia, P. & Mastrantonio, P. (2004). Comparative analysis of Clostridium difficile clinical isolates belonging to different genetic lineages and time periods. J Med Microbiol 53, 1129-1136.